Report predicts growth in U.S. SPECT and PET

07/30/2013 | AuntMinnie.com (free registration)

The U.S. market for radiopharmaceuticals and devices looks promising, thanks to emerging agents, according to a Bio-Tech Systems report. The report predicts growth in PET sales of more than 20% in 2013, fueled in part by new imaging agents for Alzheimer's disease. Sales may grow to $4.7 billion by 2021, the report found. SPECT sales growth is estimated at 6% this year, and sales could reach $1.7 billion by 2021. "This will stimulate more research and investment, adding strength and stability to venture companies, as well as those more established in the field," according to the authors of the report.

View Full Article in:

AuntMinnie.com (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA